Literature DB >> 11596652

Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil.

J I Ruiz-Sanz1, L Aldamiz-Echevarria, J Arrizabalaga, L Aquino, P Jimeno, G Pérez-Nanclares, P Sanjurjo.   

Abstract

Nutritional management of very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is based on the avoidance of fasting and substitution of medium-chain triglycerides for long- and very long-chain triglycerides. We report two cases of this disease, which developed omega-6 essential fatty acid deficiency after three and five months from the beginning of nutritional therapy (SHS product: Monogen). This alteration could be especially dangerous in these patients owing to their possible susceptibility to the development of pigmentary retinopathy. The incorporation of linoleic acid as 3-4% of total caloric intake supported as soybean oil ameliorates this deficiency. We wish to remark on this early complication in the nutritional management of VLCAD deficiency and the possibility of rescue by the incorporation of soybean oil into the diet.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596652     DOI: 10.1023/a:1010533730659

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  C O Harding; M B Gillingham; S C van Calcar; J A Wolff; J N Verhoeve; M D Mills
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis.

Authors:  J I Ruiz; B Ochoa
Journal:  J Lipid Res       Date:  1997-07       Impact factor: 5.922

3.  The long-chain acyl-CoA dehydrogenase deficiency.

Authors:  D E Hale; C A Stanley; P M Coates
Journal:  Prog Clin Biol Res       Date:  1990

4.  Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.

Authors:  M Gillingham; S Van Calcar; D Ney; J Wolff; C Harding
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

5.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.

Authors:  C Vianey-Saban; P Divry; M Brivet; M Nada; M T Zabot; M Mathieu; C Roe
Journal:  Clin Chim Acta       Date:  1998-01-12       Impact factor: 3.786

6.  Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy.

Authors:  M C Brown-Harrison; M A Nada; H Sprecher; C Vianey-Saban; J Farquhar; A C Gilladoga; C R Roe
Journal:  Biochem Mol Med       Date:  1996-06

7.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.

Authors:  T Aoyama; Y Uchida; R I Kelley; M Marble; K Hofman; J H Tonsgard; W J Rhead; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

8.  Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells.

Authors:  J T Dodge; G B Phillips
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

9.  Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria.

Authors:  I Ogilvie; M Pourfarzam; S Jackson; C Stockdale; K Bartlett; D M Turnbull
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

10.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Authors:  A Voss; M Reinhart; S Sankarappa; H Sprecher
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

View more
  1 in total

1.  Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria.

Authors:  Luis Aldámiz-Echevarría; Alfredo Vallo; Mireia Aguirre; Pablo Sanjurjo; Domingo Gonzalez-Lamuño; Javier Elorz; José Angel Prieto; Fernando Andrade; Juan Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  2006-11-23       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.